TW200730518A - Crystalline forms of docetaxel and processes for their preparation - Google Patents
Crystalline forms of docetaxel and processes for their preparationInfo
- Publication number
- TW200730518A TW200730518A TW095137557A TW95137557A TW200730518A TW 200730518 A TW200730518 A TW 200730518A TW 095137557 A TW095137557 A TW 095137557A TW 95137557 A TW95137557 A TW 95137557A TW 200730518 A TW200730518 A TW 200730518A
- Authority
- TW
- Taiwan
- Prior art keywords
- docetaxel
- processes
- preparation
- crystalline forms
- crystalline docetaxel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Novel forms of crystalline docetaxel are provided, as well as pharmaceutical compositions, and methods of treatment. Novel processes for making crystalline docetaxel are also provided.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72532105P | 2005-10-12 | 2005-10-12 | |
US72664705P | 2005-10-17 | 2005-10-17 | |
US73687005P | 2005-11-16 | 2005-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200730518A true TW200730518A (en) | 2007-08-16 |
Family
ID=37907299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095137557A TW200730518A (en) | 2005-10-12 | 2006-10-12 | Crystalline forms of docetaxel and processes for their preparation |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070142457A1 (en) |
EP (1) | EP1819688A2 (en) |
JP (1) | JP2008523111A (en) |
KR (1) | KR20070088784A (en) |
BR (1) | BRPI0606132A2 (en) |
CA (1) | CA2620308A1 (en) |
TW (1) | TW200730518A (en) |
WO (1) | WO2007044950A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101420445B1 (en) | 2005-08-31 | 2014-07-16 | 아브락시스 바이오사이언스, 엘엘씨 | Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
US8034765B2 (en) | 2005-08-31 | 2011-10-11 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
KR100995390B1 (en) | 2006-01-02 | 2010-11-19 | 주식회사 삼양제넥스 | Method for preparation of amorphous anhydrous crystalline or hydrated crystalline docetaxel |
JP2009533330A (en) | 2006-03-21 | 2009-09-17 | ドクター レディズ ラボラトリーズ リミテッド | Docetaxel polymorphs and processes |
KR101266549B1 (en) * | 2006-10-20 | 2013-05-24 | 시노팜 싱가포르 피티이 리미티드 | Process for making crystalline anhydrous docetaxel |
KR100878455B1 (en) * | 2007-04-10 | 2009-01-13 | 한미약품 주식회사 | Stable anhydrous crystalline docetaxel and method for the preparation therof |
WO2009006590A2 (en) * | 2007-07-04 | 2009-01-08 | Dr. Reddy's Laboratories Ltd. | Docetaxel process and polymorphs |
CN101337951B (en) * | 2007-07-06 | 2011-09-14 | 江苏恒瑞医药股份有限公司 | Method for preparing docetaxel anhydrous crystal |
FR2926551A1 (en) * | 2008-01-17 | 2009-07-24 | Aventis Pharma Sa | CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING SAME |
KR101068230B1 (en) * | 2009-03-03 | 2011-09-28 | 정규능 | Preparation method of a docetaxel, its intermediate product and preparation method thereof |
SG185389A1 (en) | 2010-05-03 | 2012-12-28 | Teikoku Pharma Usa Inc | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
KR20120096200A (en) * | 2011-02-22 | 2012-08-30 | 동아제약주식회사 | Crystalline form of docetaxel and process for preparation thereof |
ES2621800T3 (en) * | 2011-04-12 | 2017-07-05 | Teva Pharmaceuticals International Gmbh | Solid state forms of cabazitaxel and their preparation processes |
TWI526437B (en) * | 2011-09-09 | 2016-03-21 | 台灣神隆股份有限公司 | Crystalline forms of cabazitaxel |
US8633240B2 (en) | 2012-06-01 | 2014-01-21 | The University Of Utah Research Foundation | Paclitaxel trihydrates and methods of making thereof |
JO3685B1 (en) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | Non-aqueous taxane nanodispersion formulations and methods of using the same |
JP2018527287A (en) | 2015-05-15 | 2018-09-20 | アルブヴェックス エルエルシー | Complex of docetaxel and human serum albumin |
CN110062622B (en) | 2016-10-27 | 2022-10-14 | 珠海贝海生物技术有限公司 | Neutral pH compositions of docetaxel and human serum albumin |
CN108822062B (en) * | 2018-09-07 | 2020-08-28 | 无锡紫杉药业有限公司 | Method for refining docetaxel |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2703049B1 (en) * | 1993-03-22 | 1995-04-21 | Rhone Poulenc Rorer Sa | Method for the purification of taxoids. |
FR2722191B1 (en) * | 1994-07-08 | 1996-08-23 | Rhone Poulenc Rorer Sa | PROCESS FOR THE PREPARATION OF (2R, 3S) -3-TERTBUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE (2R, 3S) TRIHYDRATE, 20EPOXY-11BYA -13ALPHA-YLE |
US5681846A (en) * | 1995-03-17 | 1997-10-28 | Board Of Regents, The University Of Texas System | Extended stability formulations for paclitaxel |
DE19518082A1 (en) * | 1995-05-17 | 1996-11-21 | Merck Patent Gmbh | 4 (-Arylaminomethylene) -2,4-dihydropyrazol-3-one |
US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
CU22723A1 (en) * | 1997-04-02 | 2002-02-28 | Dalmer Lab Sa | HIGH MOLECULAR PRIMARY FAT ACIDS MIXTURE OBTAINED FROM THE CANA DE AZUCAR WAX AND ITS PHARMACEUTICAL USES |
MXPA04005038A (en) * | 2001-11-30 | 2004-08-11 | Bristol Myers Squibb Co | Paclitaxel solvates. |
US6838569B2 (en) * | 2002-12-16 | 2005-01-04 | Dabur India Limited | Process for preparation of paclitaxel trihydrate and docetaxel trihydrate |
CN1805968A (en) * | 2003-06-18 | 2006-07-19 | 明治制果株式会社 | Crystalline carbapenem intermediate |
-
2006
- 2006-10-12 WO PCT/US2006/040308 patent/WO2007044950A2/en active Application Filing
- 2006-10-12 EP EP06826004A patent/EP1819688A2/en not_active Withdrawn
- 2006-10-12 CA CA002620308A patent/CA2620308A1/en not_active Abandoned
- 2006-10-12 TW TW095137557A patent/TW200730518A/en unknown
- 2006-10-12 KR KR1020077015857A patent/KR20070088784A/en not_active Application Discontinuation
- 2006-10-12 US US11/580,626 patent/US20070142457A1/en not_active Abandoned
- 2006-10-12 JP JP2007545751A patent/JP2008523111A/en active Pending
- 2006-10-12 BR BRPI0606132-0A patent/BRPI0606132A2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2007044950A2 (en) | 2007-04-19 |
EP1819688A2 (en) | 2007-08-22 |
WO2007044950A3 (en) | 2007-06-14 |
JP2008523111A (en) | 2008-07-03 |
BRPI0606132A2 (en) | 2009-06-02 |
US20070142457A1 (en) | 2007-06-21 |
CA2620308A1 (en) | 2007-04-19 |
KR20070088784A (en) | 2007-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
TW200716646A (en) | (S)-N-methylnaltrexone | |
TW200720232A (en) | Crystalline solid forms of tigecycline and methods of preparing same | |
WO2006086562A3 (en) | Phenylazetidinone derivatives | |
EA200970581A1 (en) | CRISTAL TREATMENT BASIS BACKGROUND | |
MX2007008790A (en) | Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use. | |
GB2430935A (en) | Tetrapeptide analogs | |
TW200738659A (en) | Novel compounds | |
AU2010233994A8 (en) | Bispecific anti-ErbB-3/anti-c-Met antibodies | |
MX2007005221A (en) | Ascomycin crystalline forms and preparation thereof. | |
WO2008005877A3 (en) | Inhibitors of c-kit and uses thereof | |
UA95644C2 (en) | Pyridizinone derivative, pharmaceutical composition and treatment method | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
WO2008049116A3 (en) | Substituted indoles | |
MX343042B (en) | Bicyclic heteroaryl compounds. | |
TW200603798A (en) | Disalt inhibitors of il-12 production | |
TW200732340A (en) | Novel forms of tiotropium bromide and processes for preparation thereof | |
WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
TW200612892A (en) | Novel compounds | |
TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
EA200702329A1 (en) | SUBSTITUTED PYRROPHYRIDINES CONTAINING THEIR COMPOSITIONS, METHOD OF OBTAINING AND APPLICATION | |
TW200724537A (en) | Pyrimidine derivatives for treatment of hyperproliferative disorders | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
MX2009005460A (en) | (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs. | |
WO2008027600A3 (en) | Imatinib compositions |